Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With:

  • Full April issue in PDF

  • Pharmacology Watch: Estrogen Found to Not Affect Heart Disease, Breast Cancer

    Antibiotics Associated With Cancer Risk; Topiramate Effective Against Migraine; Statin Therapy For Heart Failure; FDA Actions; Drug Approved to Target Angiogenesis.
  • Prophylactic Mastectomy and the Prevention of Breast Cancer in BRCA1/2 Carriers

    In a multi-institutional cooperative effort, Rebbeck and colleagues followed the course of 105 women with either BRCA1 or BRCA2 germline mutations who had elected bilateral mastectomy as a breast cancer preventive measure. Only 2 cases of breast cancer developed in this group of operated patients compared with 184 cases in the control group, demonstrating a remarkable risk reduction of > 90%.
  • Adjuvant Vaccine for Renal Carcinoma: Finally!

    In this phase III, randomized, multicenter trial, renal carcinoma patients with organ-confined tumors were randomized after radical nephrectomy to receive autologous renal tumor cell vaccine or observation. The primary clinical outcome was the time to tumor recurrence. Patients who received the vaccine had greater 5-year and 70-month progression-free survival rates and lower tumor progression hazard rates than those in the control group.
  • Predictors of Response to Gefitinib (Iressa®)

    Gefitinib, an inhibitor of EGFR tyrosine kinase, has been demonstrated to produce clinical responses in a small number of patients with advanced non-small-cell lung cancer. Prior reviews had indicated that women and patients with adenocarcinoma histology had a somewhat higher response rate. In this review of 3 consecutive phase II trials, other clinical features were sought that might predict treatment response. Multivariable analysis revealed the presence of bronchioalveolar features and being a never smoker were additional, independent predictors of response.
  • Full May 2004 Issue in PDF

  • Updates By Carol A. Kemper, MD, FACP

    Includes the following Articles: Improved Blood Donor Screening for WNV, Azithromycin Failure as Prophylaxis or Treatment of Syphilis, United Kingdom Cracks Down on Potential Blood Donors and Human and Feline Sporotrichosis in Rio.
  • ICAAC/IDSA/ASTMH 2003 Conference Coverage

    This summary of selected abstracts from 3 meetings is published in multiple parts. The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) met in Chicago September 14-17, 2003. The Infectious Disease Society of America (IDSA) met in San Diego October 9-12, 2003. The American Society of Tropical Medicine and Hygiene met in Philadelphia December 3-7, 2003.
  • Spectrum of Disease Associated with Human Metapneumovirus Infection in Children

    Human metapneumovirus was the likely cause of 12% of all lower respiratory tract illnesses among a population of 2009 children studied from 1976 to 2001 presenting with acute respiratory symptoms. Clinical manifestations of metapneumovirus infection were bronchiolitis (59%), croup (18%), pneumonia (8%), and exacerbation of asthma (14%).
  • JCAHO Update for Infection Control: Bar also being raised for long-term care facilities

    While much attention has been paid to new hospital infection control standards for 2005, the Joint Commission also is adopting similar standards in long-term care facilities. A pre-publication edition of the new standards for long-term care, which will be effective Jan. 1, 2005, call for the following key provisions.